Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy
Authors:
Open Access
- 1 May 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Infusion Nursing
- Vol. 43 (3) , 134-145
Abstract
Hereditary angioedema (HAE) is a debilitating condition caused by a functional C1-inhibitor (C1-INH) deficiency and characterized clinically by episodes of subcutaneous or submucosal swelling. C1-INH replacement is highly effective for preventing HAE attacks and can improve health-related quality of life. Once available only for intravenous use, C1-INH is now available as a subcutaneous formulation for self-administration, shown to provide sustained plasma levels of C1-INH and reducing the monthly median HAE attack rate by 95% versus placebo in the phase 3 COMPACT study. Subcutaneously administered C1-INH satisfies multiple unmet needs in the management of patients with HAE.Keywords
This publication has 55 references indexed in Scilit:
- Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studiesOrphanet Journal of Rare Diseases, 2018
- Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedemaJournal of Allergy and Clinical Immunology, 2018
- Hereditary angioedema with normal C1 inhibitor: Four types and countingJournal of Allergy and Clinical Immunology, 2018
- Hereditary angioedema with a mutation in the plasminogen geneAllergy, 2017
- Pathogenesis of Hereditary AngioedemaImmunology and Allergy Clinics of North America, 2017
- Burden of Illness in Hereditary Angioedema: A Conceptual ModelActa Dermato-Venereologica, 2015
- Pathophysiology of Hereditary AngioedemaPediatric Allergy, Immunology, and Pulmonology, 2014
- Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working GroupAllergy, 2014
- Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedemaJournal of Allergy and Clinical Immunology, 2000
- Hereditary angioedema with normal C1-inhibitor activity in womenThe Lancet, 2000